09.09.2026, 17:46

Promomed launches flagship drug in Kazakhstan

MOSCOW. Sept 9 (Interfax) – Kazakhstan's Health Ministry has granted Promomed a registration certificate for its tirzepatide-based drug, used to treat type 2 diabetes and obesity, the Russian pharmaceutical company said.

To read the full news articles, Subscribe.

05:41PM
CPC puts Tengiz-Novorossiysk oil pipeline back into operation after planned shutdown

05:29PM
EAEU farm trade rose 20% in 2025 to $18 bln, growth continues in 2026 - Russian Agriculture Ministry

05:25PM
Kazakh, Turkmen presidents discuss joint energy, industry, transport projects

05:23PM
Australia's Lindian to invest $150 mln in Kazakh rare earth carbonate production

04:30PM
Kazatomprom holders back China uranium deal, abstain on Russian contract

04:19PM
AVERAGE WEIGHTED RATE ON OCTOBER 8, 2026 IS 448.94 TENGE FOR $1

02:33PM
Central Asian states review draft framework convention on shared water use

02:26PM
Tokayev warns of digital technology falling into terrorist, drug cartel hands

02:22PM
Tokayev seeks to raise Central Asia-Azerbaijan trade to $20 bln

01:40PM
Azerbaijan prioritizes energy, transport ties with Central Asia – Aliyev

12:34PM
Kazakhstan receives Index Watch-Positive status from J.P. Morgan

12:00PM
Kazakhstan to roll out new social benefits rules in 2027

11:35AM
Kazakhstan to build 60 bln tenge glass container plant in Aktobe

11:25AM
Earthquake strikes eastern Kazakhstan near Russian, Chinese borders

11:19AM
Tokayev begins working visit to Turkmenistan

Press center

https://press.interfax.kz

WE EXPECT A SURGE IN INFLATION IN EARLY 2026 DUE TO TAX REFORM, BUT IT WILL BE ABSORBED BY YEAR-END

KAZAKHSTAN TO ACHIEVE FULL DAIRY SELF-SUFFICIENCY BY 2027, BUT IMPORTS STILL NEEDED

KAZAKHSTAN CAN BECOME A REGIONAL LEADER IN MINERAL EXPLORATION

COUNTRIES TRYING TO BE FRIENDLY WITH EVERYONE CAN BENEFIT AND BECOME MORE ATTRACTIVE FOR INVESTMENT

Promomed launches flagship drug in Kazakhstan

Press center